Tenax Therapeutics Announces Second Quarter Fiscal Year 2015 Financial Results
Dec 17, 2014
Tenax Therapeutics to Provide Corporate Update and Discuss Second Quarter Fiscal Year 2015 Financial Results on December 17, 2014
Dec 10, 2014
Small Cap IR Issues Tenax Therapeutics Analyst Report: Large Validated Market Opportunity Inspires $12 Price Target
Nov 25, 2014
Tenax Therapeutics Analyst Brief: Emerging Biopharmaceutical Player Back In the Clinical Trial Business -- Technical Exhaustion Setup Playing Out by Small Cap Traders
Oct 31, 2014
Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results
Sep 24, 2014
Tenax Therapeutics Announces First Patients Enrolled in Phase 3 LEVO-CTS Clinical Trial of Levosimendan
Sep 22, 2014
Tenax Therapeutics to Provide Corporate Update and Discuss First Quarter Fiscal Year 2015 Financial Results on September 24, 2014
Sep 19, 2014